Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7

Biomedicine and Preventive Nutrition

Volumn 1, Issue 3, 2011, Pages 207-215

  Natarajan, Nandakumar ^a   Thamaraiselvan, Rengarajan ^a   Lingaiah, Haribabu ^a   Srinivasan, Perumal ^a   Maruthaiveeran Periyasamy, Balasubramanian ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Apoptosis; Caspase 3; GSH; Hesperidin; LDH; MCF 7; P53

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; GLUTATHIONE; HESPERIDIN; LACTATE DEHYDROGENASE; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN MCF 7; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

EID: 83655203192     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.07.001     Document Type: Article

References (75)

1. Parkin D., Muir C. Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ 1992, 120:45-173.
2. Sandhya T., Mishra K.P. Cytotoxic response of breast cancer cell lines. MCF 7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett 2006, 238:304-313.
3. Fisher B., Costantino J.P., Wickerham D.L. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388.
4. Gajalakshmi C.K., Shantha V., Swaminathan R., Sankaranarayanan R., Black R.J. A population-based survival study on female breast cancer in Madras, India. Br J Cancer 1997, 75:771-775.
5. Russo J., Fu Hu Y., Yang X., Russo I.H. Developmental, cellular and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 2000, 27:17-37.
6. IARC Monographs: In International Agency for Research on Cancer. France, Lyon, 1971-1985.
7. Wattenberg L.W. Chemoprevention of cancer by naturally occurring and synthetic compounds. Cancer chemoprevention 1985, CRC Press, Boca Raton, p.19-39. L.W. Wattenberg, M. Lipkin, C.W. Boone, G.J. Kellof (Eds.).
8. Huang H.T., Wood A.W., Newmark H.L., Sayer J.M., Yagi H., Jerina D.M., et al. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 1983, 4:1631-1637.
9. Kwon K.H., Barve A., Yu S., Huang M.T., Kong A.N.T. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 2007, 28(9):1409-1421.
10. Greenwald P. Science, medicine, and the future: cancer chemoprevention. Br Med J 2002, 324:714-718.
11. Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 2003, 33(9):421-442.
12. Johnson I.T. Phytochemicals and cancer. Proc Nutr Soc 2007, 66:207-215.
13. Russo G.L. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 2007, 74:533-544.
14. Nagamine M.K., Cristina de Silva T., Matsuzaki P., Pinello K.C., Cogliati B., Pizzo C.R., et al. Cytotoxic effect of butanolic extract from Pfaffia paniculata (Brazilian Ginseng) on cultured human breast cancer cell line MCF-7. Exp Toxicol Pathol 2009, 61:75-82.
15. Mukherjee A.K., Basu S., Sarkar N., Ghosh A.C. Advances in cancer therapy with plant based natural products. Curr Med Chem 2001, 12:1467-1486.
16. Susana B.E., Evelina G.F., Luciana N., Josefina R., Victoria S., Patricia A.M.W. Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention. J Biol Inorg Chem 2008, 13:435-447.
17. Emim J.A.D.S., Oliveira A.B., Japa A.J. Pharmcological evaluation of anti-inflammatory activity of citrus bioflavonoid, hesperidin and the isoflavonoids duratin and claussequinone, in rats and mice. J Pharm Pharmacol 1994, 46:118-122.
18. Son H.S., Kim H.S., Ju J.S. Effects of rutin and hesperidin on total cholesterol concentration, transaminase and alkaline phosphatase activity in carbon tetra chloride treated rats. Hanguk Nonghwa Hakhoe Chi 1991, 34:318-326.
19. Galati E.M., Monforte M.T., Kirjavainen S., Foretieri A.M., Tripodo M.M. Biological effects of hesperidin- a citrus flavonoid. Part 1. Anti-inflammatory and analgesic activity. Farmaco 1994, 49:709-712.
20. Yang M., Tanaka T., Hirose Y., Deguchi T., Mori H., Kawada Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Int J Cancer 1997, 73:719-724.
21. Montanari A., Chen J., Widmer W. Citrus flavonoids: a review of past biological activity against disease. Discovery of new flavonoids from Dancy tangerine cold pressed peel oil solids and leaves. Adv Exp Med Biol 1998, 439:103-116.
22. Winawer W., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterol 2003, 124:544-560.
23. Cardile V., Renis M., Scifo C., Lombardo L., Gulino R., Mancari B., et al. Behaviour of the new asbestos amphibole fluorendenitein different lung cell systems. Int J Biochem Cell Biol 2004, 36:849-860.
24. Grivell A.R., Berry M.N. The effect of phosphate and substrate free incubation conditions on glycolysis in Enrich ascites tumor cells. Biochem Biophys Acta 1996, 1291:83-88.
25. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582:67-78.
26. Chen Q., Galleano M., Cederbaum A.I. Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells over expressing human cytochrome P450 2E1. J Biol Chem 1997, 272:14532-14541.
27. Fido R.J., Tathan A.S., Shewry P.R. Western blotting analysis. Methods Mol Biol 1995, 49:423-437.
28. Morita K., Arimochi H., Ohnishi Y. In vitro cytotoxicity of 4-methyl catechol in murine tumor cells; Induction of apoptotic cell death by extra cellular pro-oxidant action. J Pharmacol Exp Ther 2003, 306:317-323.
29. Sivalokanathan S., Vijayababu M.R., Balasubramanian M.P. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J Gastroenterol 2006, 12(7):1018-1024.
30. Troyano A., Fernandez C., Sancho P., Bias de E., Aller P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-9371 promonocytic cells and the role of intracellular oxidation. J Biol Chem 2001, 276:47107-47115.
31. Rudin C.M., Yang Z., Schumaker L.M., Vander Weele D.J., Newkirk K., Egorin M.J., et al. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res 2003, 63:312-318.
32. Yano Mizoguchi A., Fukuda K., Haramaki M., Ogasawar S., Momosaki S., Kojiro M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994, 54:448-454.
33. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
34. Gooch J.L., Yee D. Strain specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett 1999, 144:31-37.
35. Storer R.D., Kraynak A.R., McKelvey T.W., Elia M.C., Goodrow T., DeLuca J.Q. The mouse lymphoma L5178Y TK+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res 1997, 373:157-165.
36. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849.
37. Graeber T.G., Peteson J.F., Tsai M., Monica K., Fornace A.J., Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low oxygen conditions is independent of p53 status. Mol Cell Biol 1994, 14:6264-6277.
38. Sun X., Shimizu H., Yamamoto K. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 1995, 15:4489-4496.
39. Linke S.P., Clarkin K.C., Di Leonardo A., Tsou A., Wahl G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996, 10:934-947.
40. Emanuele S., Calvaruso G., Lauricella M., Giuliano M., Bellavia G., D'anneo A., et al. Apoptosis induced in hepatoblastoma HepG2 cells by the proteosome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-Xs and activation of caspase-3. Int J Oncol 2002, 21:857-865.
41. Soule H.D., Vazquez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973, 51:1409-1416.
42. Russo A., Cardile V., Lombardob L., Vanella L., Garbarino J.A. Antioxidant activity and antiproliferative action of methanolic extract of Geum quellyon sweet roots in human tumor cell lines. J Ethanopharmacol 2005, 100:323-332.
43. Rodgers E.H., Grant M.H. The effect of flavonoids, querectin, myricetin and epicatechin on the growth and enzyme activities of MCF-7 human breast cancer cells. Chem Biol Interact 1998, 116:213-228.
44. Le Bail J.C., Varnat F., Nicolas J.C., Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett 1998, 130:209-216.
45. Bellocco E., Barreca D., Lagana G., Leuzzi U., Tellone E., Ficarra S., et al. Influence of L-rhamnosyl-D-glucosyl derivatives on properties and biological interaction of flavonoids. Mol Cell Biochem 2009, 321:165-171.
46. Gonazalez ME, Perles RD, Moreno DA, Viguera CG. Natural bioactive compounds of citrus lemon for food and health. J Pharm Biomed Anal 2010;51(2):327-45.
47. Rosato R.R., Almenara J.A., Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21 CIP1/WAF11. Cancer Res 2003, 63:3637-3645.
48. Valencia A., Moran J. Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Rad Biol Med 2004, 1:1112-1125.
49. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 2006;290(4):790-6.
50. Axelson K., Mannervik B. An essential role of cytosolic thiotransferase in protection of pyruvate kinase from rabbit liver against oxidative inactivation. FEBS Lett 1983, 152:114-115.
51. Miyajima A., Nakashima J., Yoshioka K., Tachibana M., Takazi H., Murai M. Role of reactive oxygen species in cis-dichlorodiammineplatinum - induced cytotoxicity on bladder cancer cells. Br J Cancer 1997, 76:206-210.
52. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391:96-99.
53. Simitzu S., Takada M., Umezawa K., Imoto M. Requirement of caspase-3 (like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998, 273:26900-26907.
54. Pelicano H., Carney D., Huang P. ROS stress in cancer cells and therapeutic implications. Drug Res Updates 2004, 7:97-110.
55. Ameyar M., Atfi A., Cai Z., Stancou R., Shatrov V., Bettaieb A., et al. Analysis of human breast adenocarcinoma MCF-7 resistance to tumor necrosis factor-induced cell death. J Biol Chem 1998, 273:29001-29008.
56. Blajeski A.L., Kottke T.J., Kaufmann S.H. A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp Cell Res 2001, 270:277-288.
57. Deepak A.V., Salimath B.P. Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF-kB and Caspase activated DNase in ascites tumour model. Biochimie 2006, 88:297-307.
58. Ko L.J., Prives C. p53: puzzle and paradigm. Gene Dev 1996, 10:1054-1072.
59. Yoshioka K., Kataoka T., Hasegawa M., Ishi Y., Hibasami H. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999, 10(9):845-851.
60. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
61. Giacca A.J., Kastan M.B. The complexity of p53 modulation emerging patterns from divergent signals. Genes Dev 1998, 12:2973-2983.
62. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-4878.
63. Xuea L., Schaldach C.M., Janosik T., Bergmanc J., Bjeldanes L.F. Effects of analogs of indole-e-carbinol cyclic trimerization product in human breast cancer cells. Chem Biol Interact 2005, 152:119-129.
64. Philchenkov A. Caspases: Potential targets for regulating cell death. J Cell Mol Med 2004, 8:432-444.
65. Verhagen A.M., Silke J., Ekert P.G., Pakesh M., Kaufmann H., Connolly L.M., et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of Apoptosis proteins. J Biol Chem 2002, 227(1):445-454.
66. Athar M, Back HJ, Kopelovich L, Bickers RD, Kim LA. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophy 2009;486(2):95-102.
67. Nunez G., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene 1998, 17:3237-3245.
68. Manion M.K., Hockenbery D.M. Targeting BCL-2-related proteins in cancer therapy. Cancer Biol Ther 2003, 2:S105-S114.
69. Yoo N.J., Lee J.W., Jeong E.G., Soung Y.H., Nam S.W., Lee J.Y. Expressional analysis of pro-apoptotic BAD gene in hepatocellular carcinomas. Dig Liver Dis 2006, 38:683-687.
70. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J 1997, 326:1-16.
71. Chen Y.L., Wang J.Y., Chen S.A., Yang B.C. Granulocytes mediates the Fas-L-associate apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. Br J Cancer 2002, 87:359-365.
72. Suzuki A., Ito T., Kawano H., Hayashida M., Hayasaki Y., Tsutomi Y. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 2000, 19:1346-1353.
73. Busihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Ann Rev Cell dev Biol 1999, 15:269-290.
74. Carlo G.D., Mascolo N., Izzo A.A., Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999, 65(4):337-353.
75. Park H.J., Kim M.J., Ha E., Chung J.H. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 2008, 15:147-151.